Martha Morrell, M.D.

Martha Morrell, M.D.

Chief Medical OfficeratNeuroPace· In proxies 2022–2025

Pay in FY2025-12% from the year before · NeuroPace stock +38.0% the same year

Martha Morrell, M.D. was paid $1.0M in FY2025 (Dec), down 12%. NeuroPace stock rose 38.0% that year.

Pay$100 in the stock at the end of FY21 → $153
Pay is from the Summary Compensation Table of each NeuroPace proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NeuroPacePublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role +38%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?